Vault-13

Kynam Capital Management, LP

PRINCETON, NJ · CIK 1907884 · 13F filing filed 2022-05-13

SEC-registered investment adviser since 2022 · limited partnership

As an employer

$307.6m reported value +64.5% vs Q4 2021
31positions
76.3%in top 10
3 new 13 added 15 reduced 2 sold out vs Q4 2021

Options: 0 call positions (— notional), 2 put positions ($661.0k notional) – listed below, not included above.

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 1,339,322 $46.4m15.08% 15.08% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 992.9k, Q1 2022 1.3m +346.4k +346,373 34.9%
2 NATERA INC COM NTRA NTRA 966,400 $39.3m12.78% 12.78% NewShares held: Q2 2021 —, Q3 2021 —, Q4 2021 0, Q1 2022 966.4k
3 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,932,800 $33.6m10.92% 10.92% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 956.2k, Q1 2022 1.9m +976.6k +976,635 102.1%
4 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 753,034 $25.6m8.34% 8.34% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 226.7k, Q1 2022 753.0k +526.3k +526,308 232.1%
5 TRAVERE THERAPEUTICS INC COM TVTX TVTX 870,918 $22.4m7.30% 7.30% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 182.1k, Q1 2022 870.9k +688.8k +688,815 378.3%
6 GOSSAMER BIO INC COM GOSS GOSS 1,832,704 $15.9m5.17% 5.17% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 1.0m, Q1 2022 1.8m +815.8k +815,847 80.2%
7 XENON PHARMACEUTICALS INC COM XENE XENE 483,270 $14.8m4.80% 4.80% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 670.1k, Q1 2022 483.3k -186.8k -186,823 -27.9%
8 VAXCYTE INC COM PCVX PCVX 579,640 $14.0m4.55% 4.55% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 211.5k, Q1 2022 579.6k +368.2k +368,157 174.1%
9 VERA THERAPEUTICS INC CL A VERA VERA 502,328 $11.8m3.84% 3.84% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 253.4k, Q1 2022 502.3k +248.9k +248,879 98.2%
10 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 589,826 $10.9m3.55% 3.55% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 287.9k, Q1 2022 589.8k +301.9k +301,892 104.8%
11 LIQUIDIA CORPORATION COM NEW LQDA LQDA 1,159,674 $8.3m2.71% 2.71% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 1.4m, Q1 2022 1.2m -207.2k -207,162 -15.2%
12 BIOGEN INC COM BIIB BIIB 38,236 $8.1m2.62% 2.62% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 40.0k, Q1 2022 38.2k -1.8k -1,764 -4.4%
13 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 2,294,082 $7.5m2.45% 2.45% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 2.2m, Q1 2022 2.3m +83.2k +83,216 3.8%
14 BURNING ROCK BIOTECH LTD SPONSORED ADS SPONSORED ADS 773,114 $7.2m2.33% 2.33% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 382.5k, Q1 2022 773.1k +390.6k +390,650 102.1%
15 SIERRA ONCOLOGY INC COM NEW COM NEW 193,280 $6.2m2.01% 2.01% NewShares held: Q2 2021 —, Q3 2021 —, Q4 2021 0, Q1 2022 193.3k
16 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 669,100 $6.0m1.95% 1.95% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 239.0k, Q1 2022 669.1k +430.1k +430,059 179.9%
17 AMICUS THERAPEUTICS INC COM FOLD FOLD 573,516 $5.4m1.77% 1.77% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 573.7k, Q1 2022 573.5k -183 -183 -0.0%
18 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 1,911,728 $3.8m1.24% 1.24% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 1.5m, Q1 2022 1.9m +417.1k +417,134 27.9%
19 FATE THERAPEUTICS INC COM FATE FATE 91,337 $3.5m1.15% 1.15% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 95.6k, Q1 2022 91.3k -4.2k -4,224 -4.4%
20 MERUS N V COM MRUS MRUS 116,764 $3.1m1.00% 1.00% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 122.2k, Q1 2022 116.8k -5.4k -5,394 -4.4%
21 SERES THERAPEUTICS INC COM COM 291,443 $2.1m0.67% 0.67% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 304.9k, Q1 2022 291.4k -13.5k -13,458 -4.4%
22 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 653,445 $1.9m0.61% 0.61% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 683.6k, Q1 2022 653.4k -30.2k -30,174 -4.4%
23 AKOUOS INC COM COM 387,892 $1.8m0.60% 0.60% AddedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 99.0k, Q1 2022 387.9k +288.9k +288,884 291.8%
24 RADIUS HEALTH INC COM NEW RDUS RDUS 185,514 $1.6m0.53% 0.53% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 194.1k, Q1 2022 185.5k -8.6k -8,568 -4.4%
25 AFFIMED N V COM COM 347,965 $1.5m0.49% 0.49% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 364.0k, Q1 2022 348.0k -16.1k -16,068 -4.4%
26 CABALETTA BIO INC COM CABA CABA 616,125 $1.3m0.41% 0.41% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 644.6k, Q1 2022 616.1k -28.5k -28,458 -4.4%
27 KRYSTAL BIOTECH INC COM KRYS KRYS 18,393 $1.2m0.40% 0.40% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 34.8k, Q1 2022 18.4k -16.4k -16,423 -47.2%
28 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 280,827 $1.2m0.39% 0.39% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 293.8k, Q1 2022 280.8k -13.0k -12,972 -4.4%
29 CONNECT BIOPHARMA HLDGS LTD ADS ADS 227,759 $688.0k0.22% 0.22% NewShares held: Q2 2021 —, Q3 2021 —, Q4 2021 0, Q1 2022 227.8k
30 NEOLEUKIN THERAPEUTICS INC COM COM 140,508 $264.0k0.09% 0.09% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 147.0k, Q1 2022 140.5k -6.5k -6,492 -4.4%
31 CATALYST BIOSCIENCES INC COM NEW COM NEW 106,089 $70.0k0.02% 0.02% ReducedShares held: Q2 2021 —, Q3 2021 —, Q4 2021 111.0k, Q1 2022 106.1k -4.9k -4,902 -4.4%

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
ZOGENIX INC ZGNX ZGNX 205,800 $3.3m205.8k shares
COGENT BIOSCIENCES INC COGT COGT 150,000 $1.3m150.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
TG THERAPEUTICS INC TGTX · Put TGTXPut 258,600 $401.0k258.6k shares New
NEKTAR THERAPEUTICS Put Put 200,000 $260.0k200.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
BURNING ROCK BIOTECH LTD 13G · filed 2026-05-15 14.0% +3.0 pts 13G 2026-05-15
SYNDAX PHARMACEUTICALS INC SNDX · 13G · filed 2025-02-14 SNDX 10.0%≈ $186.2m 13G 2025-02-14
CYTOMX THERAPEUTICS INC CTMX · 13G · filed 2026-08-14 CTMX 10.0% +3.1 pts 13G 2026-08-14
CELLDEX THERAPEUTICS INC NEW CLDX · 13G · filed 2026-08-14 CLDX 6.8% -2.0 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 5.7% +4.2 pts 13G 2026-08-14
SUTRO BIOPHARMA INC 13G · filed 2026-05-15 5.3% -1.2 pts 13G 2026-05-15
CULLINAN THERAPEUTICS INC CGEM · 13G · filed 2026-03-04 CGEM 5.3%≈ $56.7m new 13G 2026-03-04